Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nuclear chromatin patterns in normal, hyperplastic and atypical endometrium.

F A Garcia1, J R Davis, D S Alberts

  • 1Arizona Cancer Center and Optical Sciences Center, University of Arizona, Tucson, Arizona, USA.

Analytical and Quantitative Cytology and Histology
|May 3, 2001
PubMed
Summary

Endometrial lesions show significant nuclear heterogeneity, with distinct subsets of nuclei identified in hyperplasia and adenocarcinoma. This heterogeneity is crucial for understanding disease progression and evaluating chemopreventive interventions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Systematic development of a mobile preconception lifestyle programme for couples undergoing IVF: the PreLiFe-programme.

Human reproduction (Oxford, England)·2021
Same author

Quantitative evaluation of single cell spread on collagen matrices.

Experimental cell research·2016
Same author

Platinum versus platinum-combination chemotherapy in platinum-sensitive recurrent ovarian cancer: a meta-analysis using individual patient data.

Annals of oncology : official journal of the European Society for Medical Oncology·2013
Same author

Promising agents for chemoprevention of skin cancer.

Current oncology (Toronto, Ont.)·2012
Same author

Non-steroidal anti-inflammatory drugs, acetaminophen, and risk of skin cancer in the Nurses' Health Study.

Cancer causes & control : CCC·2012
Same author

Global acetylation and methylation changes predict papillary urothelial neoplasia of low malignant potential recurrence: a quantitative analysis.

International journal of immunopathology and pharmacology·2011

Area of Science:

  • Gynecologic pathology
  • Cancer research
  • Biomedical imaging

Background:

  • Endometrial lesions range from benign hyperplasia to malignant adenocarcinoma.
  • Accurate diagnosis relies on cellular morphology, particularly nuclear features.
  • Understanding nuclear heterogeneity is key to assessing disease progression.

Purpose of the Study:

  • To characterize nuclear features in normal endometrial tissue and various endometrial lesions.
  • To investigate the heterogeneity of nuclear chromatin patterns within these diagnostic categories.
  • To identify distinct nuclear subsets and their potential role in disease progression.

Main Methods:

  • High-resolution video microphotometry was used to record images of 360 nuclei per diagnostic category.

Related Experiment Videos

  • Statistical and spatial distribution features of nuclear chromatin were computed.
  • A nonsupervised learning algorithm (P-index) identified and analyzed nuclear subsets based on chromatin patterns.

    • Main Results:

    • Endometrial hyperplasia, atypical hyperplasia, and adenocarcinoma lesions each contained multiple nuclear subsets with statistically significant differences in chromatin patterns.
    • A discernible trend of progression towards adenocarcinoma was observed in specific nuclear subsets across diagnostic categories.
    • Nuclear heterogeneity was a prominent feature in all studied endometrial lesions.

    Conclusions:

    • Endometrial lesions exhibit substantial nuclear heterogeneity, comprising distinct subsets of nuclei.
    • Assessing lesion progression or regression from chemopreventive treatments requires analyzing the proportion of nuclei within each subset.
    • Future evaluations should consider nuclear subset proportions and deviations from normal for accurate clinical assessment.